// June 08, 2023
Insights from India: Q&A with USP nitrosamines expert
The issue of addressing potential nitrosamine impurities in medicines has been the focus at event
The issue of addressing potential nitrosamine impurities in medicines has been the focus at event
Interest in innovative vaccines that use messenger ribonucleic acid (mRNA) and viral vectored tec
USP has launched the newest tool in our suite of solutions to address the evolving nitrosamines c
Revised on: January 17, 2023